COP vs NPCE · P/E 19, rev $58.94B vs rev $79.9M
ConocoPhillips (COP) versus Neuropace Inc (NPCE) — a side-by-side from cached financials, not a winner call.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Neuropace Inc (NPCE) is a medical devices company listed on US.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Latest reported NPCE revenue for 2024-12-31 was $79.9M. Net income was -$27.1M. Revenue was up 22.1% from 2023-12-31 to 2024-12-31. NPCE currently screens at market cap $312.2M.
COP currently screens at market cap $135.49B and trailing P/E 18.8. NPCE currently screens at market cap $312.2M.
Not investment advice. Open the COP and NPCE stock pages for the full models.
Not investment advice.